Updated July 2026 · 8 min read
Part of the ICU Emergencies Hub — browse every related guide in one place.
Most nurses learn to think of liver failure as a problem of the liver cells themselves — hepatitis, alcohol, acetaminophen. Budd-Chiari syndrome is different: the liver tissue is often fine to begin with, but the veins that carry blood out of it clot off, so the organ becomes an engorged, high-pressure sponge that cannot drain. The result is a patient with a triad that should raise a flag — abdominal pain, a large tender liver, and ascites that seems to appear out of nowhere — and a condition that can smolder for months or crash into acute liver failure over days.
The liver receives blood from two sources — the hepatic artery and the portal vein — and it all leaves through the hepatic veins into the inferior vena cava and back to the heart. Budd-Chiari syndrome is what happens when that single exit is blocked. Blood keeps arriving but cannot depart, so pressure builds inside the liver, the sinusoids engorge, and the organ swells against its capsule — which is why the pain and tenderness are real and why the liver is enlarged rather than shrunken. That backed-up pressure is transmitted upstream into the portal system, producing portal hypertension and its familiar consequences: ascites (often protein-rich and rapidly reaccumulating), splenomegaly, and eventually varices. If the congestion is severe and sudden, the hepatocytes at the center of each lobule — the ones furthest from the arterial supply — begin to die from a combination of stagnation and pressure, and the picture tips toward acute hepatic injury or failure. This is the same congestive logic seen in mesenteric venous thrombosis, just applied to the liver's drainage instead of the bowel's.
Budd-Chiari is, in the majority of cases, a manifestation of an underlying prothrombotic state, so the diagnosis should trigger a hunt for why this patient's blood wants to clot.
| Category | Examples |
|---|---|
| Myeloproliferative neoplasms | Polycythemia vera, essential thrombocythemia (often JAK2-positive) — the single most common association |
| Inherited thrombophilia | Factor V Leiden, prothrombin mutation, protein C/S or antithrombin deficiency |
| Acquired hypercoagulability | Antiphospholipid syndrome, paroxysmal nocturnal hemoglobinuria, pregnancy and estrogen/oral contraceptives, malignancy |
| Mechanical/local | Tumor invasion (hepatocellular or renal), IVC webs, infection or trauma near the veins |
The presentation runs a wide spectrum. Some patients are chronic, discovered when longstanding cirrhosis-like disease and ascites are worked up. Some are subacute, with weeks of pain and swelling. And some are fulminant, arriving with jaundice, coagulopathy, and encephalopathy over days — the version most likely to land in the ICU. Diagnosis is usually made by Doppler ultrasound of the hepatic veins (looking for absent or reversed flow), confirmed with CT or MR venography, and the workup always includes a search for the hypercoagulable driver.
The nursing role in Budd-Chiari sits at the intersection of three familiar ICU jobs: managing anticoagulation, managing portal hypertension and its ascites, and watching for the slide into liver failure. Once the diagnosis is made and there is no contraindication, anticoagulation is started early to stop the clot from extending and to give a stepwise approach to reopening flow, so the nurse anticipates the heparin order, titrates per protocol, and watches for bleeding — a patient with portal hypertension and a failing liver is already coagulopathic, which makes the bleeding-versus-clotting balance genuinely delicate. Alongside that, the pressure needs relief: many patients go for angioplasty/stenting of a discrete stenosis or a TIPS (transjugular intrahepatic portosystemic shunt) to decompress the congested liver, and the nurse preps and recovers these patients, monitoring for post-procedure bleeding and for new or worsening encephalopathy, which a shunt can precipitate by diverting blood past the liver. Day to day, the ascites is managed with sodium restriction, diuretics as tolerated, and therapeutic paracentesis for tense, uncomfortable, or breathing-limiting fluid, with the nurse tracking weights, girth, and respiratory status. Overlaying all of it is surveillance for acute liver failure: trend the INR, bilirubin, transaminases, ammonia trajectory, and mental status, because a Budd-Chiari patient who develops rising bilirubin, a climbing INR, and worsening confusion may be crossing into fulminant failure that needs transplant evaluation.
Budd-Chiari syndrome is liver failure caused from the outside in — not sick cells, but a blocked exit that dams blood inside the organ until it swells, hurts, and leaks fluid into the belly. Its signature is the triad of abdominal pain, tender hepatomegaly, and ascites in a patient whose blood has a reason to clot, most often a myeloproliferative disorder. The treatment is a layered one — anticoagulate to stop the clot, decompress with angioplasty or a shunt to relieve the pressure, tap and diurese the ascites, and stand ready with transplant evaluation if the liver tips into failure. The nurse who connects fresh ascites and a painful liver to a clotting history, who manages the anticoagulation and the portal hypertension in tandem, and who watches the INR, bilirubin, and mental status for the fulminant turn is the one who helps a treatable venous problem from becoming an irreversible one.
Related: Mesenteric venous thrombosis · Acute liver failure · Hepatic encephalopathy · Massive transfusion protocol
Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.